China Shandong Network - Perception Of Shandong July 8, July 7 to July 8, Shandong Provincial Market Supervision Bureau Deputy Secretary of the Party Group, Provincial Food and Drug Administration Party Group Secretary, Director Yu Tao, Provincial Food and Drug Administration Party Group Member, Deputy Director Ren Shaoyan and his party came to Hehe to investigate, and signed a strategic cooperation agreement with the municipal government.
During the investigation, Yu Tao and his party listened to the report on the drug safety work and the development of the biomedical industry in Heze City, and visited Shandong Erye Pharmaceutical Co., Ltd. in Dingtao District, yibaijia comprehensive outpatient vaccination site in the development zone, Heze Modern Pharmaceutical Port and other units and enterprises, learned more about the drug safety supervision and the development of the biomedical industry, and comforted the front-line drug safety supervisors.
On the morning of July 8, the Provincial Food and Drug Administration and the Heze Municipal Government held a signing ceremony. Yu Tao, Secretary of the Party Group and Director of the Provincial Food and Drug Administration, and Zhang Lun, Deputy Secretary of the Municipal Party Committee and Mayor, attended the signing ceremony and delivered speeches; Ren Shaoyan, member of the party group and deputy director of the Provincial Food and Drug Administration, and Nie Yuanke, vice mayor, signed the strategic cooperation framework agreement on behalf of the two sides. According to the framework agreement, the Heze Municipal People's Government will deeply implement the territorial management responsibility for drug safety, further increase the supervision of drug safety, increase the support of drug inspection and research and development platforms, and resolutely ensure the safety of drug use by the people. Yu Tao said that the Provincial Food and Drug Administration will conscientiously implement the measures of the agreement, promote system innovation and process reengineering, provide more efficient and convenient service guidance, and give full support to Heze in accelerating the improvement of regulatory capabilities, key core technology research, innovative product listing, high-quality project landing, pharmaceutical talent training, etc., to help Heze build a 100-billion-level biomedical industry cluster, and work together to create a "Heze model" for improving drug safety governance capabilities and high-quality development of the pharmaceutical industry.
Zhang Kui, director of the Municipal Market Supervision Bureau, and responsible persons of relevant departments, and Li Juan, director of the Sixth Branch of the Provincial Food and Drug Administration, accompanied the activities.